NPM1 Gene Mutations Can Be Confidently Identified in Blood DNA Months Before De Novo AML Onset

Overview

Journal Blood Adv

Specialty Hematology

Date 2021 Dec 17

PMID 34920452

Citations 3

Authors

Pedro M Quiros

Muxin Gu

Clea Barcena

Vivek Iyer

George S Vassiliou

Affiliations

Soon will be listed here.

Citing Articles

Clonal hematopoiesis and hematological malignancy.

Dunn W, McLoughlin M, Vassiliou G J Clin Invest. 2024; 134(19).

PMID: 39352393 PMC: 11444162. DOI: 10.1172/JCI180065.

Multiparameter prediction of myeloid neoplasia risk.

Gu M, Kovilakam S, Dunn W, Marando L, Barcena C, Mohorianu I Nat Genet. 2023; 55(9):1523-1530.

PMID: 37620601 PMC: 10484784. DOI: 10.1038/s41588-023-01472-1.

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 () Mutation.

Chin L, Wong C, Gill H Int J Mol Sci. 2023; 24(4).

PMID: 36834572 PMC: 9958584. DOI: 10.3390/ijms24043161.

References

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87. PMC: 4290021. DOI: 10.1056/NEJMoa1409405. View

Sellar R, Jaiswal S, Ebert B . Predicting progression to AML. Nat Med. 2018; 24(7):904-906. DOI: 10.1038/s41591-018-0114-7. View

Pollyea D, Stevens B, Jones C, Winters A, Pei S, Minhajuddin M . Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018; 24(12):1859-1866. PMC: 7001730. DOI: 10.1038/s41591-018-0233-1. View

Montalban-Bravo G, Kanagal-Shamanna R, Sasaki K, Patel K, Ganan-Gomez I, Jabbour E . mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy. Blood Adv. 2019; 3(6):922-933. PMC: 6436014. DOI: 10.1182/bloodadvances.2018026989. View

Burnett A, Hills R, Milligan D, Kjeldsen L, Kell J, Russell N . Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial. J Clin Oncol. 2010; 29(4):369-77. DOI: 10.1200/JCO.2010.31.4310. View

Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik V, Paschka P, Roberts N . Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016; 374(23):2209-2221. PMC: 4979995. DOI: 10.1056/NEJMoa1516192. View

Dohner H, Weisdorf D, Bloomfield C . Acute Myeloid Leukemia. N Engl J Med. 2015; 373(12):1136-52. DOI: 10.1056/NEJMra1406184. View

Bycroft C, Freeman C, Petkova D, Band G, Elliott L, Sharp K . The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018; 562(7726):203-209. PMC: 6786975. DOI: 10.1038/s41586-018-0579-z. View

10.

Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L . Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005; 352(3):254-66. DOI: 10.1056/NEJMoa041974. View

11.

McKerrell T, Park N, Moreno T, Grove C, Ponstingl H, Stephens J . Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 2015; 10(8):1239-45. PMC: 4542313. DOI: 10.1016/j.celrep.2015.02.005. View

12.

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N . The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. PMC: 2723002. DOI: 10.1093/bioinformatics/btp352. View

13.

Abelson S, Collord G, Ng S, Weissbrod O, Mendelson Cohen N, Niemeyer E . Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018; 559(7714):400-404. PMC: 6485381. DOI: 10.1038/s41586-018-0317-6. View

14.

Desai P, Mencia-Trinchant N, Savenkov O, Simon M, Cheang G, Lee S . Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med. 2018; 24(7):1015-1023. PMC: 6849383. DOI: 10.1038/s41591-018-0081-z. View

15.

Dohner K, Schlenk R, Habdank M, Scholl C, Rucker F, Corbacioglu A . Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood. 2005; 106(12):3740-6. DOI: 10.1182/blood-2005-05-2164. View

16.

Khwaja A, Bjorkholm M, Gale R, Levine R, Jordan C, Ehninger G . Acute myeloid leukaemia. Nat Rev Dis Primers. 2016; 2:16010. DOI: 10.1038/nrdp.2016.10. View

17.

Uckelmann H, Kim S, Wong E, Hatton C, Giovinazzo H, Gadrey J . Therapeutic targeting of preleukemia cells in a mouse model of mutant acute myeloid leukemia. Science. 2020; 367(6477):586-590. PMC: 7754791. DOI: 10.1126/science.aax5863. View

18.

Gu M, Zwiebel M, Ong S, Boughton N, Nomdedeu J, Basheer F . RNAmut: robust identification of somatic mutations in acute myeloid leukemia using RNA-sequencing. Haematologica. 2019; 105(6):e290-e293. PMC: 7271607. DOI: 10.3324/haematol.2019.230821. View

19.

Xie M, Lu C, Wang J, McLellan M, Johnson K, Wendl M . Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014; 20(12):1472-8. PMC: 4313872. DOI: 10.1038/nm.3733. View

20.

Falini B, Brunetti L, Sportoletti P, Martelli M . NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood. 2020; 136(15):1707-1721. DOI: 10.1182/blood.2019004226. View